文献速递慢阻肺

COPD患者血清Sirtuin-1水平降低

Decreased Serum Sirtuin-1 in COPD.
PubMed 文献 · Chest · 2017-05-12

s120S与气流阻塞程度、肺弥散功能、BMI呈正相关,与肺气肿严重程度及频繁急性加重史呈负相关,提示其可能作为COPD部分疾病特征的生物标志物。

要点

  • s120S与FEV1/FVC、FEV1%pred、KCO%及BMI呈正相关。
  • s120S随肺气肿加重及频繁急性加重史而降低。

核心结论

  • COPD患者血清120 kDa SIRT1水平降低,可能反映细胞内SIRT1因氧化应激而减少。
  • s120S可能是COPD某些疾病特征的潜在生物标志物。

研究设计与样本

  • 研究检测所有样本的血清SIRT1蛋白,采用Western blot法,计算SIRT1蛋白条带密度并与临床参数比较。

临床怎么用

  • s120S可能作为评估COPD气流阻塞、肺气肿及急性加重风险的潜在血清标志物。

局限性

  • 正常培养条件下A549和原代上皮细胞上清中未检测到SIRT1。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The protein deacetylase sirtuin-1 (SIRT1) is an antiaging molecule that is decreased in the lung in patients with COPD. Recently, SIRT1 was reported to be detectable in serum, but serum SIRT1 (s120S) levels have not yet been reported in patients with COPD. METHODS: Serum SIRT1 protein of all samples was measured by Western blot, and the SIRT1 protein band densities were calculated and compared with clinical parameters. RESULTS: Several molecular sizes of SIRT1, including 120 kDa (actual size) and fragments (102 and 75 kDa) were quantified by Western blot. Among them, only the 120-kDa s120S was significantly decreased in patients with COPD compared with the control subjects without COPD (s120S ratio in healthy subjects = 0.90 ± 0.34 vs those with COPD = 0.68 ± 0.24; P = .014) and was positively correlated with airway obstruction (FEV1/FVC, r = 0.31; P = .020); its severity measured by FEV1 % predicted (r = 0.29; P = .029). s120S also showed a positive correlation with BMI (r = 0.36; P = .0077) and diffusing capacity of the lung per unit volume (the carbon monoxide transfer coefficient: KCO%) (r = 0.32; P = .025). It was also significantly decreased with increasing severity of lung emphysema (r = -0.40; P = .027) and with a clinical history of frequent COPD exacerbations (infrequent vs frequent, 0.76 ± 0.20 vs 0.56 ± 0.26; P = .027). SIRT1 was not detected in supernatant of A549 and primary epithelial cells in normal culture conditions. CONCLUSIONS: s120S was decreased in the patients with COPD, potentially as reflected by the reduced SIRT1 within cells as a result of oxidative stress, and might be a potential biomarker for certain disease characteristics of COPD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Yanagisawa S, Papaioannou AI, Papaporfyriou A, et al. Decreased Serum Sirtuin-1 in COPD. Chest. 2017. PMID: 28506610. doi:10.1016/j.chest.2017.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。